Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
726 Multiple Sclerosis
clinical trials

Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
University of Kansas Medical Center
mi
from
Kansas City, KS
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
Sibyl Wray Neurology, PC
mi
from
Knoxville, TN
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
The Neurology Foundation, Inc.
mi
from
Providence, RI
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
Raleigh Neurology Associates
mi
from
Raleigh, NC
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
Infinity Clinical Research, LLC
mi
from
Sunrise, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
Multicare Neuroscience Center of Washington
mi
from
Tacoma, WA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)
Status: Enrolling, Phase III
Updated: 12/31/1969
Associated Neurologists, P.C.
mi
from
Danbury, CT
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Lipoic Acid for Progressive Multiple Sclerosis (MS)
Status: Enrolling, Phase II
Updated: 12/31/1969
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Lipoic Acid for Progressive Multiple Sclerosis (MS)
Status: Enrolling, Phase II
Updated: 12/31/1969
Washington DC VA Medical Center, Washington, DC
mi
from
Washington DC,
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)
Status: Enrolling, Phase IV
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)
Status: Enrolling, Phase IV
Updated: 12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 12/31/1969
The Research Center of Southern California
mi
from
Carlsbad, CA
Click here to add this to my saved trials
Neurology, Other, Reproductive Clinical Trial
PREG-MS: New England MS Pregnancy Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Healthy Volunteer Clinical Trial
MS PATHS Normative Sub-Study
Status: Enrolling, Phase
Updated: 12/31/1969
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Comparative Effectiveness Study Telerehab Versus Conventional
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Comparative Effectiveness Study Telerehab Versus Conventional
Status: Enrolling
Updated: 12/31/1969
Marquette University
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology, Other Clinical Trial
Measurement and Training of Dual-Task of Gait in Persons With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Texas Woman's University, Institute of Health Sciences- Houston Center
mi
from
Houston, TX
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Histaminergic Basis of Central Fatigue in Multiple Sclerosis - A Novel Approach
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Cognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis Fatigue
Status: Enrolling, Phase IV
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Study of the Combined Effect of Transcranial Direct Current Stimulation (tDCS) and Physical Activity on Gait and Functional Mobility in Participants With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative site
mi
from
Aurora, CO
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Boulder, CO
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Fullerton, CA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Knoxville, TN
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Sherman, TX
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis
Status: Upcoming, Phase I
Updated: 2/22/2016
Multiple Sclerosis Center Oregon Health & Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Short-term B-cell Depletion in Relapsing Multiple Sclerosis
Status: Upcoming, Phase IV
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety and Brain Protection Effects of the Green Tea Extract Theaphenon 95% (95% Pure EGCG) in Multiple Sclerosis
Status: Upcoming, Phase II
Updated: 10/2/2015
Lsu Health Sciences Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Augmenting Cerebral Blood Flow to Treat Established Multiple Sclerosis
Status: Upcoming, Phase II
Updated: 12/31/1969
UTHealth
mi
from
Houston, TX
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Ocrelizumab Effects on the Metabolome in MS
Status: Upcoming, Phase
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Neurology, Other Clinical Trial
A Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis
Status: Upcoming, Phase II, III
Updated: 2/22/2016
Multiple Sclerosis Center Oregon Health & Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
LoveYourBrain Yoga for Multiple Sclerosis
Status: Upcoming
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Neurology, Rheumatology, Other Clinical Trial
Impact of Acute Leg Cycling at Various Intensities on RLS Severity in Persons With MS
Status: Upcoming
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis
Status: Upcoming, Phase II
Updated: 2/22/2016
OHSU MS Center
mi
from
Portland, OR
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Multi-joint Muscle Fatigability and Gait Performance in People With Multiple Sclerosis
Status: Upcoming, Phase
Updated: 12/31/1969
Washington DC VA Medical Center
mi
from
Washington DC,
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Carbondale, IL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Cedarhurst, NY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Foxboro, MA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Louisville, CO
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Merrillville, IN
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Placentia, CA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Richland, WA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Stafford, TX
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Wisconsin Rapids, WI
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Biogen Multiple Sclerosis Pregnancy Exposure Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cambridge, MA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Asheville, NC
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Danbury, CT
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Des Moines, IA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Edina, MN
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hartford, CT
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Livingston, NJ
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Monroeville, PA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Neenah, WI
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Overland Park, KS
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Plainview, NY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rockport, ME
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Springfield, MO
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Washington DC,
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
West Long Branch, NJ
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Cullman, AL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Lenexa, KS
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Naples, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Sarasota, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Online Program to Reduce Depression in MS
Status: Enrolling
Updated: 12/31/1969
University of Missouri, Kansas City
mi
from
Kansas City, KS
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
Oklahoma Medical Research Foundation; MS Center of Excellence
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
Neurological Associates Inc; Clinical Research
mi
from
Richmond, VA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
UCSF- Multiple Sclerosis Centre; Department of Neurology
mi
from
San Francisco, CA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 5/8/2017
Swedish Neuroscience Institute; Multiple Sclerosis Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Use of Cellular Stromal Vascular Fraction in Multiple Sclerosis,Autoimmune, Inflammatory, Neurologic Conditions
Status: Enrolling
Updated: 12/31/1969
Regenevita LLC
mi
from
Stevensville, MT
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)
Status: Enrolling, Phase III
Updated: 12/31/1969
Henry Ford Health System - Neurology
mi
from
Detroit, MI
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)
Status: Enrolling, Phase III
Updated: 12/31/1969
NYU Langone Medical Center - MS Comprehensive Care Center
mi
from
New York, NY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)
Status: Enrolling, Phase III
Updated: 12/31/1969
Neurology and Neuromuscular Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)
Status: Enrolling, Phase III
Updated: 12/31/1969
Neurology Assoc of Ormond Beach - CNS Trials
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)
Status: Enrolling, Phase IV
Updated: 12/31/1969
Mt. Sinai University
mi
from
New York, NY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Corrona Multiple Sclerosis (MS) Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Corrona, LLC
mi
from
Waltham, MA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Tele-Exercise and Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Cornerstone Rehabilitation
mi
from
Batesville, MS
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Tele-Exercise and Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Drayer Physical Therapy Institute
mi
from
Cool Springs, TN
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Tele-Exercise and Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Gulf Coast Therapy
mi
from
Foley, AL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Tele-Exercise and Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Montgomery East Physical Therapy
mi
from
Montgomery, AL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Tele-Exercise and Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Drayer Physical Therapy Institute
mi
from
Saltillo, MS
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Safety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking Impairment
Status: Enrolling, Phase III
Updated: 12/31/1969
Adamas Clinical Site
mi
from
Patchogue, NY
Click here to add this to my saved trials
1 2 3 4 5 6 7